Home›Stocks›BIOF

BIOF — structural market context

Blue Biofuels, Inc.

Structural market context from public regulatory and market data, shown with its as-of dates. Descriptive only: nothing on this page is a recommendation, a prediction, or advice to buy or sell any security.

What changed

As of the close on Oct 22. Each line shows the earlier value, the later value and their dates.

Short interest

Short interest 235K shares (settlement Sep 30) vs 136K (Sep 15).

No new publication in this window. Latest: settlement Sep 30, published Oct 10.

Fails-to-deliver

Latest file (settlements Sep 15–Sep 30, published Oct 16): 6 days with fails, largest 85K shares on Sep 29.

Previous file (settlements Sep 1–Sep 14, published Sep 30): 8 days with fails, largest 1.5M shares on Sep 9.

No new publication in this window.

Insider filings (Form 4)

None recorded in this window.

BIOF events and their magnitude

Latest SEC filing in the event study

No SEC filing for this ticker in the event study yet.

…

Open the Event Study →

BIOF short interest & days to cover

SHARES SHORT
235K
% OF FLOAT
0.1%
DAYS TO COVER
1.0
CHANGE VS PRIOR
+72.7%

FINRA consolidated short interest, reported twice a month and published ~2 weeks after each settlement date. % of float uses reported free float. · as of 2026-09-30 (23d ago)

BIOF fails-to-deliver (FTD)

Settlement dateFailed sharesPrice
2026-09-30 · 23d46K$0.11
2026-09-29 · 24d85K$0.11
2026-09-24 · 29d6K$0.1

SEC fails-to-deliver files, published twice a month with ~6 weeks of delay.

BIOF insider buying and selling (Form 4)

Last 12 months, Form 4 codes P and S: 0 purchases · 0 sales · 4 filings not counted

InsiderTypeSharesValueFiled
Kneppers Chris J · directorSale (S)126K—*2026-10-22
Kneppers Chris J · directorSale (S)100K—*2026-10-15
Kneppers Chris J · directorSale (S)200K—*2026-09-08
Kneppers Chris J · directorSale (S)300K—*2026-09-08
Kneppers Chris J · directorSale (S)700K—*2026-09-03

*Value not shown: the filed price could not be checked against the U.S. listing.

SEC Form 4 filings: purchases and sales reported on Form 4 (transaction codes P and S) only; grants and option exercises excluded. Attributed public records.

Frequently asked questions

What is BIOF's short interest?
As of the FINRA settlement date 2026-09-30, BIOF had 235K shares sold short — 0.1% of its float, with 1.0 days to cover at average volume. FINRA publishes this data roughly two weeks after each twice-monthly settlement, so it is inherently delayed. A short-interest figure describes an aggregate position; it does not predict what the stock will do.
Are insiders buying BIOF?
In the last 12 months of SEC Form 4 filings, BIOF recorded 0 insider purchases and 0 sales reported on Form 4 (transaction codes P and S; grants and option exercises excluded). 4 filings not counted: the filed price could not be checked against the U.S. listing. These are attributed public records — information, not instruction.
Is this page telling me to buy or sell BIOF?
No. Everything on this page is descriptive, structural market context from public data, shown with its as-of dates. TradeAI News does not issue directional recommendations, price predictions, or buy/sell advice — for any ticker.
All covered stocksShort Interest & FTD trackerInsider Buying trackerThe platform

More tickers starting with B

B · Barrick Mining CorporationBAM · Brookfield Asset Management LtBAND · Bandwidth Inc.BBNX · Beta Bionics, Inc.BE · Bloom Energy CorporationBEAM · Beam Therapeutics Inc.All B →

BIOF: the full history

Latest rows shown. Full history, market-wide screens, cluster detection and the context journal live in the dashboard.

Start free →View plans →

Not financial advice. Trading involves risk. Descriptive structural context, never a recommendation.